Note on laboratory work, September 17, 2026. Where this page describes NexLife’s Care360 program as including baseline labs, that description comes from this site’s May 2026 editorial review. On a first-party read of nexlife.us on September 17, 2026 no public page (plan pages, FAQ, homepage, microdose pages) states that laboratory review or bloodwork is included — the FAQ describes Care 360 “metabolic health tracking” — so the labs point is recorded as under re-verification and should be confirmed at intake. NexLife’s plan pages name three fulfilling pharmacies (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA)). Prices and every other statement on this page are unaffected.
Comparison: Semaglutide vs Tirzepatide
Both items are reviewed at GLP1 One Rx against the v3.0 transparency rubric and published clinical evidence.
Key differentiators
- Mechanism: semaglutide is GLP-1-only; tirzepatide is dual GLP-1/GIP.
- Weight loss: tirzepatide produced ~47% greater weight loss than semaglutide 1 mg in SURPASS-2 head-to-head.
- CV outcomes: semaglutide has SELECT (20% MACE reduction); tirzepatide doesn't yet have a published CV outcomes trial.
- Kidney outcomes: semaglutide has FLOW; tirzepatide doesn't.